Revumenib 160mg Tablet – Imported | Lucius Pharmaceuticals

Product Overview

Revumenib 160mg Tablet – Imported is an oral prescription medicine containing revumenib, a targeted anticancer agent known as a menin inhibitor. Revumenib is used to treat certain types of acute leukemia when specific genetic abnormalities are present and the patient’s condition meets the relevant treatment criteria.

It is approved for certain cases of relapsed or refractory acute leukemia associated with a KMT2A gene translocation, and for relapsed or refractory acute myeloid leukemia (AML) with a susceptible NPM1 mutation in eligible patients who have no satisfactory alternative treatment options.

Revumenib works by targeting menin-related molecular pathways involved in leukemia-cell development. Treatment requires specialist supervision, genetic testing where indicated, and regular monitoring for serious adverse reactions.

MedicineWalyDost.com provides product information for customers looking for imported specialty medicines in Pakistan. Contact the team to confirm the product’s availability, packaging, manufacturer details, and current price.

Key Product Information

• Product Name: Revumenib 160mg Tablet
• Active Ingredient: Revumenib
• Strength: 160mg
• Dosage Form: Oral tablet
• Manufacturer Listed: Lucius Pharmaceuticals
• Pack Size: 30 tablets
• Product Type: Imported medicine
• Therapeutic Category: Antineoplastic agent / menin inhibitor
• Primary Treatment Area: Selected forms of acute leukemia
• Prescription Requirement: Specialist-prescribed medicine

Please verify the manufacturer, product identity, and packaging against the original product label before listing or purchasing.

Uses of Revumenib 160mg Tablet

Revumenib is prescribed for selected patients with acute leukemia based on specific genetic findings and specialist assessment.

1. Acute Leukemia With a KMT2A Translocation

Revumenib is indicated for eligible adult and pediatric patients aged one year and older with relapsed or refractory acute leukemia associated with a KMT2A gene translocation, confirmed using an appropriate diagnostic test.

2. Acute Myeloid Leukemia (AML) With an NPM1 Mutation

Revumenib is also indicated for eligible patients aged one year and older with relapsed or refractory AML carrying a susceptible NPM1 mutation when satisfactory alternative treatment options are unavailable.

3. Targeted Leukemia Treatment

Revumenib targets a molecular pathway involved in abnormal leukemia-cell development. It may be considered by a specialist when the patient’s disease characteristics meet the treatment criteria.

Important: Revumenib is not a general treatment for every type of leukemia. Appropriate genetic testing and specialist evaluation are essential.

How Does Revumenib Work?

Revumenib inhibits the interaction between menin and specific leukemia-associated proteins. In certain leukemias, this interaction contributes to abnormal gene activity that supports the survival and development of cancer cells.

By inhibiting this pathway, revumenib can help promote the differentiation of abnormal leukemia cells and reduce the disease burden in appropriately selected patients.

Treatment response varies, and the medicine requires ongoing assessment by a hematologist or oncologist.

How to Take Revumenib 160mg Tablet

• Take the medicine exactly as prescribed by your treating specialist.
• Follow the prescribed schedule and administration instructions.
• The approved product information specifies administration twice daily, with fasting or low-fat-meal instructions according to the prescribing guidance.
• Swallow tablets whole unless the product’s official instructions and your healthcare professional advise otherwise.
• Do not increase, decrease, or discontinue the dose without medical advice.
• If you miss a dose, follow the instructions supplied with your medicine or contact your treatment team.

The appropriate dose depends on factors including body weight, the prescribed regimen, and interacting medicines. A 160mg tablet is a strength, not necessarily the complete dose for every patient.

Possible Side Effects of Revumenib

Revumenib may cause side effects that require clinical monitoring. Report new or worsening symptoms to your healthcare team.

Reported adverse reactions include:

• Nausea
• Diarrhea
• Fatigue
• Reduced appetite
• Constipation
• Muscle or joint pain
• Swelling or fluid retention
• Abnormal liver-function tests
• Changes in blood-cell counts
• Electrolyte abnormalities
• Changes in heart rhythm measurements
• Infections or fever

The frequency and severity of side effects vary between patients.

Serious Warnings

Differentiation syndrome: This potentially life-threatening reaction can cause fever, breathing difficulties, low oxygen levels, rapid weight gain, swelling, low blood pressure, or reduced urine output. Seek immediate medical attention if these symptoms develop.

QTc prolongation and serious heart-rhythm problems: Revumenib can affect the heart’s electrical activity and may cause dangerous arrhythmias. Fainting, loss of consciousness, or a racing or irregular heartbeat requires urgent assessment.

Embryo-fetal toxicity: Revumenib may harm an unborn baby. Discuss effective contraception and pregnancy-related precautions with your specialist.

Precautions and Warnings

Before starting Revumenib 160mg Tablet, inform your doctor about your medical history and all medicines you take.

Important precautions include:

• Blood tests: Blood counts and other laboratory parameters require monitoring.
• Heart monitoring: ECG assessments and electrolyte checks may be needed before and during treatment.
• Liver function: Your specialist may monitor liver enzymes and adjust treatment when necessary.
• Pregnancy: Discuss pregnancy risks and appropriate contraception with your healthcare professional.
• Breastfeeding: Breastfeeding is not recommended during treatment according to the prescribing information.
• Infection risk: Report fever or symptoms of infection promptly.
• Treatment interruptions: Do not independently change your treatment schedule.

Revumenib should only be used under the supervision of a qualified specialist experienced in treating acute leukemia.

Drug Interactions

Revumenib can interact with medicines that affect its metabolism or increase the risk of heart-rhythm abnormalities.

Tell your healthcare professional about all prescription medicines, nonprescription products, vitamins, and supplements you use.

Important interaction groups include:

• Strong CYP3A4 inhibitors, which may require a dose adjustment
• Strong or moderate CYP3A4 inducers, which may need to be avoided
• Medicines that prolong the QT interval and increase the risk of abnormal heart rhythms
• Other medicines that affect electrolyte levels or cardiac function

Never start, stop, or change another medicine without consulting your treating specialist.

Who Should Use Revumenib 160mg Tablet?

Revumenib may be prescribed for patients with specific forms of relapsed or refractory acute leukemia whose disease meets the relevant genetic and clinical criteria.

A hematologist or oncologist must determine whether treatment is appropriate after reviewing diagnostic results, previous treatments, body weight, medical history, and potential drug interactions.

It is not suitable for self-medication or for treating leukemia without a confirmed diagnosis and specialist supervision.

Storage Instructions

• Follow the storage conditions printed on the original product packaging.
• Keep the medicine in its original packaging where appropriate.
• Protect it from excessive heat and moisture.
• Keep it out of reach of children.
• Do not use the medicine after its expiry date.
• Consult a pharmacist if the packaging is damaged or the product’s authenticity is uncertain.

Why Choose MedicineWalyDost.com?

MedicineWalyDost.com helps customers in Pakistan explore information about imported and specialty medicines.

For Revumenib 160mg Tablet, contact the team to enquire about:

• Current product availability
• Latest price in Pakistan
• Manufacturer and packaging verification
• Pack size and expiry information
• Prescription requirements
• Delivery arrangements

Product availability and all packaging details should be confirmed before placing an order.

Frequently Asked Questions (FAQs)

1. What is Revumenib 160mg Tablet used for?

It is a targeted prescription medicine used for certain types of relapsed or refractory acute leukemia associated with specific KMT2A translocations or susceptible NPM1 mutations in eligible patients.

2. Who is the manufacturer of Revumenib 160mg Tablet?

Lucius Pharmaceuticals is the manufacturer specified for this listing. Verify the actual manufacturer’s name on the supplied packaging before purchase.

3. What is the pack size of Revumenib 160mg Tablet?

The listed pack size is 30 tablets.

4. Is Revumenib a chemotherapy medicine?

Revumenib is a targeted anticancer medicine classified as a menin inhibitor. It differs from conventional chemotherapy in how it targets leukemia-associated molecular pathways.

5. Can Revumenib 160mg Tablet be taken without a prescription?

No. It requires specialist prescribing and monitoring. Do not use it without medical supervision.

6. What is the price of Revumenib 160mg Tablet in Pakistan?

The current price depends on availability and the verified product supplied. Contact MedicineWalyDost.com for updated pricing information.

7. What serious side effects should patients know about?

Differentiation syndrome and QTc prolongation with potentially dangerous heart rhythms are major warnings. Breathing difficulties, rapid swelling or weight gain, fainting, or an irregular heartbeat require immediate medical attention.

Order Revumenib 160mg Tablet – Imported in Pakistan

Looking for Revumenib 160mg Tablet, pack of 30? Contact MedicineWalyDost.com to confirm availability, current price, manufacturer details, prescription requirements, and delivery arrangements in Pakistan.

For patient safety, obtain prescription oncology medicines only from an appropriate, verified supplier and use them under the supervision of a qualified hematologist or oncologist.